Seven hundred patients with 735 urinary calculi were studied for the compositions of calculi by infrared analysis and for stone recurrence. Of these 700 cases, 422 cases were possible to follow up, and 250 cases have had no further stone; 138 cases experienced recurring stones, and 34 cases had multiple stones. The length of follow-up period was 1–19 years averaging 8 years, 8 months. 41.2% of patients with calcium oxalate-calcium phosphate calculi had stones recurrently, and although there was some variation of recurrence rates for patients with various proportions of oxalate to phosphate in the calculi, it was impossible to predict the tendency of recurrence by these proportions. The stone recurrence was noted in 38.6% of patients with magnesium ammonium phosphate calculi, in 38.9% with mixed magnesium ammonium phosphate-calcium oxalate calculi, in 55.6% with uric acid calculi, and in 50% with cystine calculi.

Keywords:
Calculus, Stone recurrence, Stone composition
This content is only available via PDF.
© 1975 S. Karger AG, Basel
1975
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.